全文获取类型
收费全文 | 5709篇 |
免费 | 349篇 |
国内免费 | 46篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 94篇 |
妇产科学 | 70篇 |
基础医学 | 669篇 |
口腔科学 | 132篇 |
临床医学 | 505篇 |
内科学 | 1788篇 |
皮肤病学 | 61篇 |
神经病学 | 492篇 |
特种医学 | 185篇 |
外科学 | 874篇 |
综合类 | 17篇 |
预防医学 | 169篇 |
眼科学 | 126篇 |
药学 | 316篇 |
中国医学 | 14篇 |
肿瘤学 | 574篇 |
出版年
2022年 | 63篇 |
2021年 | 111篇 |
2020年 | 47篇 |
2019年 | 81篇 |
2018年 | 107篇 |
2017年 | 91篇 |
2016年 | 104篇 |
2015年 | 148篇 |
2014年 | 132篇 |
2013年 | 152篇 |
2012年 | 282篇 |
2011年 | 348篇 |
2010年 | 143篇 |
2009年 | 143篇 |
2008年 | 241篇 |
2007年 | 292篇 |
2006年 | 238篇 |
2005年 | 273篇 |
2004年 | 232篇 |
2003年 | 268篇 |
2002年 | 242篇 |
2001年 | 219篇 |
2000年 | 280篇 |
1999年 | 201篇 |
1998年 | 69篇 |
1997年 | 41篇 |
1996年 | 57篇 |
1995年 | 44篇 |
1994年 | 45篇 |
1993年 | 35篇 |
1992年 | 153篇 |
1991年 | 140篇 |
1990年 | 116篇 |
1989年 | 149篇 |
1988年 | 103篇 |
1987年 | 83篇 |
1986年 | 82篇 |
1985年 | 82篇 |
1984年 | 49篇 |
1983年 | 55篇 |
1982年 | 25篇 |
1981年 | 21篇 |
1980年 | 21篇 |
1979年 | 45篇 |
1978年 | 22篇 |
1976年 | 20篇 |
1975年 | 22篇 |
1972年 | 21篇 |
1971年 | 19篇 |
1970年 | 17篇 |
排序方式: 共有6104条查询结果,搜索用时 15 毫秒
101.
More than 10 years of follow-up of two patients after total femur replacement for malignant bone tumor 总被引:2,自引:0,他引:2
Nakamura S Kusuzaki K Murata H Takeshita H Hirata M Hashiguchi S Hirasawa Y 《International orthopaedics》2000,24(3):176-178
One patient with osteosarcoma and one with Ewing’s sarcoma of the femur were in 1987 and 1988 treated with prosthetic replacement
of the femur and chemotherapy. There has been no loosening of the prostheses and no recurrence of the tumor. The patients
have maintained 60% and 63% limb function scores evaluated by ISOLS criteria.
Accepted: 17 March 2000 相似文献
Résumé Deux patients, l’un avec un ostéosarcome, l’autre avec un sarcome d’EWING, furent opérés en 1987–1988 avec remplacement prothétique du fémur, associéà une chimiothérapie. Ces patients ont été suivis sans qu’il soit noté de récidive. Il n’y a pas de descellement, ni de luxation de la prothèse. Un score fonctionnel évalué selon les critères de l’ISOLS, montre une conservation de 60% et 63% de la fonction du membre inférieur.
Accepted: 17 March 2000 相似文献
102.
We have found previously that expansion of the Wallerian degenerated nerve was accompanied by accelerated Schwann cell proliferation. In this study, we investigated the usefulness of the elongation of Wallerian degenerated nerve for the repair of short nerve gap. Male Wistar rats were used. After the left sciatic nerve was transected the rats were divided into 4 groups. In the control group, nerve coaptation was not performed. In group 1, tensionless coaptation was performed immediately. In group 2, delayed tensionless coaptation was performed with the elongation of Wallerian degenerated nerve. In group 3, coaptation was performed immediately with autologous interposition nerve graft. The ideal tensionless nerve repair of group 1 was considered to produce the best result. Rats in group 2 showed functional recovery as good as rats in group 1. On histologic assessment, in group 2, a fibrous capsule that was very rich in vascularity was formed around the tissue expander. After 14 weeks, the capsule was diminished markedly in size, but the vascularity was rich around the sciatic nerve. We think that the excellent functional recovery seen in group 2 can be attributed to the increased activity of Schwann cell proliferation and increased vascularity. 相似文献
103.
Takeshi Tominaga Hiroki Koyama Tetsuya Toge Shigeto Miura Keizo Sugimachi Susumu Yamaguchi Koichi Hirata Yasumasa Monden Yasuo Nomura Masakazu Toi Izo Kimijima Shinzaburo Noguchi Hiroshi Sonoo Kazuaki Asaishi Tadashi Ikeda Tadaoki Morimoto Jun Ota Yasuo Ohashi Osahiko Abe 《Journal of clinical oncology》2003,21(6):991-998
PURPOSE: We compared the therapeutic usefulness of doxifluridine (5'-DFUR) alone and a combination of 5'-DFUR plus cyclophosphamide (CPM), both of which are considered effective against advanced and recurrent breast cancer, to determine which treatment is more beneficial as postoperative adjuvant chemotherapy. PATIENTS AND METHODS: A total of 1,131 women with node-positive primary breast cancer were randomly assigned after primary surgery to receive 5'-DFUR alone or 5'-DFUR plus CPM. All patients initially received 5'-DFUR in an oral dose of 1,200 mg/d for 4 weeks, starting 4 weeks after surgery. Chemotherapy was then not given for 2 weeks. Patients in the 5'-DFUR group subsequently received five 4-week cycles of treatment consisting of oral 5'-DFUR (1,200 mg/d) for the first 2 weeks and no chemotherapy for the next 2 weeks. Those assigned to the 5'-DFUR plus CPM group also received oral CPM 100 mg/d for the first 2 weeks and no chemotherapy for the next 2 weeks. Women 50 years or older concurrently received 20 mg/d of tamoxifen for 2 years in both groups. RESULTS: Of the 1,088 eligible women, 546 were assigned to receive 5'-DFUR alone and 542 were assigned to receive 5'-DFUR plus CPM. Overall disease-free survival was significantly better in women who received 5'-DFUR plus CPM than in those who received 5'-DFUR alone (log-rank test, P =.021). Toxic effects occurred in 20.0% of patients (109 of 546) in the 5'-DFUR group and 32.3% of patients (175 of 542) in the 5'-DFUR plus CPM group (chi(2) test, P <.001). CONCLUSION: Combination therapy with 5'-DFUR plus CPM is more effective in preventing recurrence than 5'-DFUR alone. 相似文献
104.
105.
106.
107.
108.
109.
110.
Zou XM Hirata K Katsurama T Nie G Yang WL Shan SG Jiang XH Sun ZH Oikawa I 《Transplantation proceedings》2000,32(7):2335-2337